Neilston, United Kingdom

Robert M Christie

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: The Australian National University. Active years: 1983-1987.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1983-1987

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Robert M Christie

Introduction

Robert M Christie is a notable inventor based in Neilston, GB. He has made significant contributions to the field of prostanoid preparation, holding a total of 2 patents. His work has implications in various medical applications, showcasing his expertise and dedication to innovation.

Latest Patents

Christie's latest patents include a process for the preparation of prostanoids. The compounds of the general formula I are disclosed as useful intermediates in the preparation of prostanoids, wherein A represents O or H, OR^z. Additionally, he has developed a 4-Oxy-cyclopent-2-en-1-one derivative, which serves as a prostaglandin intermediate. These innovations highlight his commitment to advancing medical science through his research.

Career Highlights

Robert M Christie is affiliated with The Australian National University, where he continues to contribute to research and development in his field. His work has garnered attention for its potential applications in medicine, particularly in the synthesis of important compounds.

Collaborations

Some of his notable coworkers include Melvyn Gill and Rodney W Rickards. Their collaborative efforts have likely enhanced the quality and impact of their research projects.

Conclusion

Robert M Christie is a distinguished inventor whose work in prostanoid preparation has led to valuable patents and advancements in medical science. His contributions reflect a strong commitment to innovation and collaboration in research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…